Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.39 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.39 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.39 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13031053 | 0.92 | POLB (0.61) | POLBLMNAKMT2AL3MBTL1NT5E | |
| SCHEMBL6810337 | 0.88 | POLB (0.55) | POLBLMNAKMT2AL3MBTL1NT5E | |
| SCHEMBL6810335 | 0.86 | POLB (0.52) | POLBLMNAKMT2AL3MBTL1SSTR1 | |
| SCHEMBL15143128 | 0.81 | L3MBTL1 (0.50) | POLBLMNAKMT2AL3MBTL1SSTR1 | |
| SCHEMBL5428265 | 0.81 | SSTR5 (0.47) | POLBLMNAKMT2AL3MBTL1SSTR1 | |
| SCHEMBL15504415 | 0.81 | POLB (0.58) | POLBLMNAKMT2AL3MBTL1SSTR1 | |
| SCHEMBL19786845 | 0.80 | LMNA (0.53) | POLBLMNAKMT2AL3MBTL1MEN1 | |
| SCHEMBL5028352 | 0.80 | PTPN1 (0.54) | POLBKMT2AL3MBTL1NT5EMEN1 | |
| SCHEMBL4402910 | 0.80 | FGF2 (0.41) | POLBLMNAKMT2ANT5EMEN1 | |
| SCHEMBL17850343 | 0.80 | LMNA (0.57) | POLBLMNAKMT2AL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286067-A1 | GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES | BIOGENERIX AG (DE) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286067-A1 | GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES | GALNT2, GALNT6, GALNT1 | POLB 1053/4885LMNA 951/4885KMT2A 3613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.